CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $25.1 million in its third quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 67 cents.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.

The gene therapy company posted revenue of $1.5 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News